Clinical Impact of an Antimicrobial Stewardship Program on Pediatric Hospitalist Practice, a 5-Year Retrospective

Russell J McCulloh1, Mary Ann Queen2, Brian Lee2

  • 1Departments of Pediatrics, and rmcculloh@cmh.edu.

Hospital Pediatrics
|October 3, 2015
PubMed

Insights

Pediatric hospitalists and antimicrobial stewardship programs (ASPs) can collaborate effectively. Hospitalists agreed with most ASP recommendations, and disagreement was linked to a shorter hospital stay but not readmission rates.

Area of Science:

  • Pediatric hospital medicine
  • Infectious disease management
  • Antimicrobial stewardship

Background:

  • Hospitalists are primary physicians for children with infections.
  • Hospitalists frequently collaborate with antimicrobial stewardship programs (ASPs).
  • Understanding hospitalist-ASP interactions can improve care.

Purpose of the Study:

  • Identify factors associated with ASP recommendations in hospitalist-managed children.
  • Determine the impact of ASP interventions on clinical outcomes for these patients.

Main Methods:

  • Retrospective analysis of ASP reviews for hospitalist patients (March 2008-June 2013).
  • Clinical factors linked to ASP recommendations were identified.
  • Length of stay and 30-day readmission were compared between agreement and disagreement with ASP recommendations.

Main Results:

  • The ASP reviewed 2163 patients, issuing 350 recommendations (16.2%).
  • Hospitalists agreed with 86.9% of recommendations; disagreement was associated with a 15.4-hour shorter stay.
  • Ceftriaxone and community-acquired pneumonia were most frequently associated with recommendations.

Conclusions:

  • Pediatric hospitalists and ASPs can collaborate effectively for improved antibiotic use and safe patient care.
  • Further research is needed to understand and address areas of disagreement.
  • Identifying beneficial ASP strategies for various hospitalist settings is crucial.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
375
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467